ASRS
ENTA icon

Arizona State Retirement System’s Enanta Pharmaceuticals ENTA Stock Holding History

Arizona State Retirement System’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,724
Closed -$231K – 2194
2023
Q1 		$231K Buy
5,724
+169
+3% +$8.07K ﹤0.01% 1857
2022
Q4 		$258K Buy
5,555
+208
+4% +$9.48K ﹤0.01% 1761
2022
Q3 		$277K Buy
5,347
+62
+1% +$3.62K ﹤0.01% 1678
2022
Q2 		$250K Buy
5,285
+340
+7% +$18.5K ﹤0.01% 1785
2022
Q1 		$352K Buy
4,945
+48
+1% +$3.12K ﹤0.01% 1694
2021
Q4 		$366K Sell
4,897
-54
-1% -$4.24K ﹤0.01% 1717
2021
Q3 		$281K Buy
4,951
+16
+0.3% +$791 ﹤0.01% 1879
2021
Q2 		$217K Sell
4,935
-33
-0.7% -$1.62K ﹤0.01% 2080
2021
Q1 		$245K Buy
4,968
+31
+0.6% +$1.55K ﹤0.01% 1931
2020
Q4 		$208K Sell
4,937
-194
-4% -$8.54K ﹤0.01% 1934
2020
Q3 		$235K Buy
+5,131
New +$249K ﹤0.01% 1709
2020
Q1 		– Sell
-10,655
Closed -$658K – 1888
2019
Q4 		$658K Sell
10,655
-8,069
-43% -$500K 0.01% 1248
2019
Q3 		$1.13M Sell
18,724
-5,991
-24% -$445K 0.01% 1185
2019
Q2 		$2.08M Buy
24,715
+422
+2% +$38K 0.02% 966
2019
Q1 		$2.32M Buy
24,293
+64
+0.3% +$5.74K 0.03% 902
2018
Q4 		$1.72M Buy
24,229
+1,460
+6% +$112K 0.02% 1020
2018
Q3 		$1.95M Buy
22,769
+1,687
+8% +$169K 0.02% 1077
2018
Q2 		$2.44M Sell
21,082
-1,615
-7% -$161K 0.02% 901
2018
Q1 		$1.84M Sell
22,697
-1,300
-5% -$100K 0.02% 1070
2017
Q4 		$1.41M Buy
23,997
+16,597
+224% +$831K 0.01% 1272
2017
Q3 		$346K Buy
7,400
+200
+3% +$8.04K ﹤0.01% 1380
2017
Q2 		$259K Hold
7,200
– – ﹤0.01% 1418
2017
Q1 		$222K Hold
7,200
– – ﹤0.01% 1437
2016
Q4 		$241K Buy
+7,200
New +$206K ﹤0.01% 1426
2016
Q1 		– Sell
-6,400
Closed -$211K – 1478
2015
Q4 		$211K Buy
6,400
+100
+2% +$3.26K ﹤0.01% 1398
2015
Q3 		$228K Buy
+6,300
New +$271K ﹤0.01% 1374

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arizona State Retirement System's ENTA Position: Q2 2023 in Review

Arizona State Retirement System sold out of Enanta Pharmaceuticals (ENTA) in Q2 2023, closing a stake of 5,724 shares — an estimated $231K sold.

Arizona State Retirement System first reported a position in ENTA in Q3 2015 and held it in 26 quarters. The position peaked at $2.44M in Q2 2018. 133 funds tracked by Wall St. Rank hold ENTA as of Q2 2023.

  • Arizona State Retirement System reported no remaining Enanta Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 5,724 Enanta Pharmaceuticals shares in Q2 2023, an estimated $231K.
  • Arizona State Retirement System first reported a position in Enanta Pharmaceuticals in Q3 2015 and held it in 26 quarters.
  • Arizona State Retirement System's Enanta Pharmaceuticals position peaked at $2.44M in Q2 2018.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2023.

Based on Arizona State Retirement System's 13F filing for Q2 2023, filed 1 Aug 2023.